AIGH Capital Management’s Cellectar Biosciences, Inc. Series A Warrants CLRBZ Stock Holding History

AIGH Capital Management’s Portfolio CLRBZ Stock Details CLRBZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-583,037	Closed	-$1.23M	–	72
2020 Q4	$1.23M	Buy	+583,037	New	+$84.8K	0.5%	38

Other funds holding CLRBZ

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

AIGH Capital Management's CLRBZ Position: Q1 2021 in Review

AIGH Capital Management sold out of Cellectar Biosciences, Inc. Series A Warrants (CLRBZ) in Q1 2021, closing a stake of 583,037 shares — an estimated $1.23M sold.

AIGH Capital Management first reported a position in CLRBZ in Q4 2020 and held it in 1 quarter. The position peaked at $1.23M in Q4 2020. 2 funds tracked by Wall St. Rank hold CLRBZ as of Q1 2021.

AIGH Capital Management reported no remaining Cellectar Biosciences, Inc. Series A Warrants position as of Q1 2021 after selling out during the quarter.
AIGH Capital Management sold 583,037 Cellectar Biosciences, Inc. Series A Warrants shares in Q1 2021, an estimated $1.23M.
AIGH Capital Management first reported a position in Cellectar Biosciences, Inc. Series A Warrants in Q4 2020 and held it in 1 quarter.
AIGH Capital Management's Cellectar Biosciences, Inc. Series A Warrants position peaked at $1.23M in Q4 2020.
2 funds tracked by Wall St. Rank held Cellectar Biosciences, Inc. Series A Warrants as of Q1 2021.

Based on AIGH Capital Management's 13F filing for Q1 2021, filed 13 May 2021.